Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Effects of a Recreational Team Handball-based Programme on Health and Physical Fitness of Postmenopausal Women (H4HW)

28. mars 2022 oppdatert av: Susana Cristina Araújo Póvoas, University Institute of Maia

Effects of a Short- and Long-term Team Handball-based Exercise Programme on Physical Fitness and Health Status of Inactive Postmenopausal Women

This study aimed at determining the short- (16 weeks) and long-term (36 weeks) health and physical fitness effects and adherence of recreational team handball training for postmenopausal women without previous experience with the sport.

The investigators hypothesized that short-term recreational team handball training would result in positive health and physical fitness adaptations and that the health and physical fitness improvements achieved after the first 16 weeks would be maintained or further improved at the long-term. Moreover, the investigators also hypothesized that the adherence to this exercise mode would be maintained throughout the 36 weeks (long-term) compared to the first 16 weeks (short-term).

Studieoversikt

Status

Fullført

Forhold

Intervensjon / Behandling

Studietype

Intervensjonell

Registrering (Faktiske)

80

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiesteder

  • Portugal
    • Porto
      • Maia, Porto, Portugal, 4476-690
        • University of Maia

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

  • Barn
  • Voksen
  • Eldre voksen

Tar imot friske frivillige

Nei

Kjønn som er kvalifisert for studier

Hunn

Beskrivelse

Inclusion Criteria:

  • Inactive postmenopausal women aged +55 years or younger if with menopause for at least 3 years

Exclusion Criteria:

  • Any medical contraindications to perform moderate-to-vigorous physical activity

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Forebygging
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Enkelt

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: Team handball group
The team handball group participants were encouraged to performed at least two out of three weekly supervised team handball training sessions of 60 min each, for 36 weeks.
Annen: Recreational team handball
Two to three weekly sessions of recreational team handball training for 36 weeks. Each 60-min session started with a standardised warm-up (including running, coordination, strength, flexibility, and balance exercises) followed by three 15-min periods of recreational team handball matches, interspersed by 2-min breaks, played as small-sided games (4v4, 5v5 or 6v6). The training sessions were performed on an indoor team handball court (40x20 m) adjusted to result in 34-36 m2 per player. During the matches, the participants rotated positions every 3 min in a random order, including the goalkeeper and no exclusions or substitutions were applied.
Ingen inngripen: Control group
The control group participants were instructed to keep their regular daily physical activity for 36 weeks.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Between group differences in peak oxygen uptake at week 16
Tidsramme: Week 16
Determined by pulmonary gas exchange measurements, during an incremental treadmill test until voluntary exhaustion.
Week 16
Between group differences in peak oxygen uptake at week 36
Tidsramme: Week 36
Determined by pulmonary gas exchange measurements, during an incremental treadmill test until voluntary exhaustion.
Week 36
Changes from baseline in peak oxygen uptake at week 16
Tidsramme: Baseline and week 16
Determined by pulmonary gas exchange measurements, during an incremental treadmill test until voluntary exhaustion.
Baseline and week 16
Changes from baseline in peak oxygen uptake at week 36
Tidsramme: Baseline and week 36
Determined by pulmonary gas exchange measurements, during an incremental treadmill test until voluntary exhaustion.
Baseline and week 36
Changes from week 16 in peak oxygen uptake at week 36
Tidsramme: Week 16 and week 36
Determined by pulmonary gas exchange measurements, during an incremental treadmill test until voluntary exhaustion.
Week 16 and week 36

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Between group differences in resting heart rate at week 16
Tidsramme: Week 16
Determined by an automatic upper arm blood pressure monitor according to standardized procedures.
Week 16
Between group differences in resting heart rate at week 36
Tidsramme: Week 36
Determined by an automatic upper arm blood pressure monitor according to standardized procedures.
Week 36
Changes from baseline in resting heart rate at week 16
Tidsramme: Baseline and week 16
Determined by an automatic upper arm blood pressure monitor according to standardized procedures.
Baseline and week 16
Changes from baseline in resting heart rate at week 36
Tidsramme: Baseline and week 36
Determined by an automatic upper arm blood pressure monitor according to standardized procedures.
Baseline and week 36
Changes from week 16 in resting heart rate at week 36
Tidsramme: Week 16 and week 36
Determined by an automatic upper arm blood pressure monitor according to standardized procedures.
Week 16 and week 36
Between group differences in body mass at week 16
Tidsramme: Week 16
Determined by whole-body dual- energy X-ray absorptiometry following standard procedures.
Week 16
Between group differences in body mass at week 36
Tidsramme: Week 36
Determined by whole-body dual- energy X-ray absorptiometry following standard procedures.
Week 36
Changes from baseline in body mass at week 16
Tidsramme: Baseline and week 16
Determined by whole-body dual- energy X-ray absorptiometry following standard procedures.
Baseline and week 16
Changes from baseline in body mass at week 36
Tidsramme: Baseline and week 36
Determined by whole-body dual- energy X-ray absorptiometry following standard procedures.
Baseline and week 36
Changes from week 16 in body mass at week 36
Tidsramme: Week 16 and week 36
Determined by whole-body dual- energy X-ray absorptiometry following standard procedures.
Week 16 and week 36
Between group differences in fat mass at week 16
Tidsramme: Week 16
Determined by whole-body dual- energy X-ray absorptiometry following standard procedures.
Week 16
Between group differences in fat mass at week 36
Tidsramme: Week 36
Determined by whole-body dual- energy X-ray absorptiometry following standard procedures.
Week 36
Changes from baseline in fat mass at week 16
Tidsramme: Baseline and week 16
Determined by whole-body dual- energy X-ray absorptiometry following standard procedures.
Baseline and week 16
Changes from baseline in fat mass at week 36
Tidsramme: Baseline and week 36
Determined by whole-body dual- energy X-ray absorptiometry following standard procedures.
Baseline and week 36
Changes from week 16 in fat mass at week 36
Tidsramme: Week 16 and week 36
Determined by whole-body dual- energy X-ray absorptiometry following standard procedures.
Week 16 and week 36
Between group differences in lean mass at week 16
Tidsramme: Week 16
Determined by whole-body dual- energy X-ray absorptiometry following standard procedures.
Week 16
Between group differences in lean mass at week 36
Tidsramme: Week 36
Determined by whole-body dual- energy X-ray absorptiometry following standard procedures.
Week 36
Changes from baseline in lean mass at week 16
Tidsramme: Baseline and week 16
Determined by whole-body dual- energy X-ray absorptiometry following standard procedures.
Baseline and week 16
Changes from baseline in lean mass at week 36
Tidsramme: Baseline and week 36
Determined by whole-body dual- energy X-ray absorptiometry following standard procedures.
Baseline and week 36
Changes from week 16 in lean mass at week 36
Tidsramme: Week 16 and week 36
Determined by whole-body dual- energy X-ray absorptiometry following standard procedures.
Week 16 and week 36
Between group differences in lumbar spine bone mineral density at week 16
Tidsramme: Week 16
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Week 16
Between group differences in lumbar spine bone mineral density at week 36
Tidsramme: Week 36
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Week 36
Changes from baseline in lumbar spine bone mineral density at week 16
Tidsramme: Baseline and week 16
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Baseline and week 16
Changes from baseline in lumbar spine bone mineral density at week 36
Tidsramme: Baseline and week 36
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Baseline and week 36
Changes from week 16 in lumbar spine bone mineral density at week 36
Tidsramme: Week 16 and week 36
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Week 16 and week 36
Between group differences in dominant femur bone mineral density at week 16
Tidsramme: Week 16
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Week 16
Between group differences in dominant femur bone mineral density at week 36
Tidsramme: Week 36
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Week 36
Changes from baseline in dominant femur bone mineral density at week 16
Tidsramme: Baseline and week 16
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Baseline and week 16
Changes from baseline in dominant femur bone mineral density at week 36
Tidsramme: Baseline and week 36
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Baseline and week 36
Changes from week 16 in dominant femur bone mineral density at week 36
Tidsramme: Week 16 and week 36
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Week 16 and week 36
Between group differences in dominant femoral neck bone mineral density at week 16
Tidsramme: Week 16
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Week 16
Between group differences in dominant femoral neck bone mineral density at week 36
Tidsramme: Week 36
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Week 36
Changes from baseline in dominant femoral neck bone mineral density at week 16
Tidsramme: Baseline and week 16
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Baseline and week 16
Changes from baseline in dominant femoral neck bone mineral density at week 36
Tidsramme: Baseline and week 36
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Baseline and week 36
Changes from week 16 in dominant femoral neck bone mineral density at week 36
Tidsramme: Week 16 and week 36
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Week 16 and week 36
Between group differences in lumbar spine bone mineral content at week 16
Tidsramme: Week 16
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Week 16
Between group differences in lumbar spine bone mineral content at week 36
Tidsramme: Week 36
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Week 36
Changes from baseline in lumbar spine bone mineral content at week 16
Tidsramme: Baseline and week 16
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Baseline and week 16
Changes from baseline in lumbar spine bone mineral content at week 36
Tidsramme: Baseline and week 36
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Baseline and week 36
Changes from week 16 in lumbar spine bone mineral content at week 36
Tidsramme: Week 16 and week 36
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Week 16 and week 36
Between group differences in dominant femur bone mineral content at week 16
Tidsramme: Week 16
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Week 16
Between group differences in dominant femur bone mineral content at week 36
Tidsramme: Week 36
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Week 36
Changes from baseline in dominant femur bone mineral content at week 16
Tidsramme: Baseline and week 16
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Baseline and week 16
Changes from baseline in dominant femur bone mineral content at week 36
Tidsramme: Baseline and week 36
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Baseline and week 36
Changes from week 16 in dominant femur bone mineral content at week 36
Tidsramme: Week 16 and week 36
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Week 16 and week 36
Between group differences in dominant femoral neck bone mineral content at week 16
Tidsramme: Week 16
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Week 16
Between group differences in dominant femoral neck bone mineral content at week 36
Tidsramme: Week 36
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Week 36
Changes from baseline in dominant femoral neck bone mineral content at week 16
Tidsramme: Baseline and week 16
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Baseline and week 16
Changes from baseline in dominant femoral neck bone mineral content at week 36
Tidsramme: Baseline and week 36
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Baseline and week 36
Changes from week 16 in dominant femoral neck bone mineral content at week 36
Tidsramme: Week 16 and week 36
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Week 16 and week 36
Between group differences in osteocalcin at week 16
Tidsramme: Week 16
Determined by chemiluminescence method using a fully automated immunoassay system.
Week 16
Between group differences in osteocalcin at week 36
Tidsramme: Week 36
Determined by chemiluminescence method using a fully automated immunoassay system.
Week 36
Changes from baseline in osteocalcin at week 16
Tidsramme: Baseline and week 16
Determined by chemiluminescence method using a fully automated immunoassay system.
Baseline and week 16
Changes from baseline in osteocalcin at week 36
Tidsramme: Baseline and week 36
Determined by chemiluminescence method using a fully automated immunoassay system.
Baseline and week 36
Changes from week 16 in osteocalcin at week 36
Tidsramme: Week 16 and week 36
Determined by chemiluminescence method using a fully automated immunoassay system.
Week 16 and week 36
Between group differences in procollagen type-1 amino-terminal propeptide at week 16
Tidsramme: Week 16
Determined by chemiluminescence method using a fully automated immunoassay system.
Week 16
Between group differences in procollagen type-1 amino-terminal propeptide at week 36
Tidsramme: Week 36
Determined by chemiluminescence method using a fully automated immunoassay system.
Week 36
Changes from baseline in procollagen type-1 amino-terminal propeptide at week 16
Tidsramme: Baseline and week 16
Determined by chemiluminescence method using a fully automated immunoassay system.
Baseline and week 16
Changes from baseline in procollagen type-1 amino-terminal propeptide at week 36
Tidsramme: Baseline and week 36
Determined by chemiluminescence method using a fully automated immunoassay system.
Baseline and week 36
Changes from week 16 in procollagen type-1 amino-terminal propeptide at week 36
Tidsramme: Week 16 and week 36
Determined by chemiluminescence method using a fully automated immunoassay system.
Week 16 and week 36
Between group differences in carboxy-terminal type-1 collagen crosslinks at week 16
Tidsramme: Week 16
Determined by chemiluminescence method using a fully automated immunoassay system.
Week 16
Between group differences in carboxy-terminal type-1 collagen crosslinks at week 36
Tidsramme: Week 36
Determined by chemiluminescence method using a fully automated immunoassay system.
Week 36
Changes from baseline in carboxy-terminal type-1 collagen crosslinks at week 16
Tidsramme: Baseline and week 16
Determined by chemiluminescence method using a fully automated immunoassay system.
Baseline and week 16
Changes from baseline in carboxy-terminal type-1 collagen crosslinks at week 36
Tidsramme: Baseline and week 36
Determined by chemiluminescence method using a fully automated immunoassay system.
Baseline and week 36
Changes from week 16 in carboxy-terminal type-1 collagen crosslinks at week 36
Tidsramme: Week 16 and week 36
Determined by chemiluminescence method using a fully automated immunoassay system.
Week 16 and week 36
Between group differences in sclerostin at week 16
Tidsramme: Week 16
Determined by chemiluminescence method using a fully automated immunoassay system.
Week 16
Between group differences in sclerostin at week 36
Tidsramme: Week 36
Determined by chemiluminescence method using a fully automated immunoassay system.
Week 36
Changes from baseline in sclerostin at week 16
Tidsramme: Baseline and week 16
Determined by chemiluminescence method using a fully automated immunoassay system.
Baseline and week 16
Changes from baseline in sclerostin at week 36
Tidsramme: Baseline and week 36
Determined by chemiluminescence method using a fully automated immunoassay system.
Baseline and week 36
Changes from week 16 in sclerostin at week 36
Tidsramme: Week 16 and week 36
Determined by chemiluminescence method using a fully automated immunoassay system.
Week 16 and week 36
Between group differences in isometric knee extension peak torque at week 16
Tidsramme: Week 16
Determined by a Biodex isokinetic dynamometer, during a isometric knee extension contraction
Week 16
Between group differences in isometric knee extension peak torque at week 36
Tidsramme: Week 36
Determined by a Biodex isokinetic dynamometer, during a isometric knee extension contraction
Week 36
Changes from baseline in isometric knee extension peak torque at week 16
Tidsramme: Baseline and week 16
Determined by a Biodex isokinetic dynamometer, during a isometric knee extension contraction
Baseline and week 16
Changes from baseline in isometric knee extension peak torque at week 36
Tidsramme: Baseline and week 36
Determined by a Biodex isokinetic dynamometer, during a isometric knee extension contraction
Baseline and week 36
Changes from week 16 in isometric knee extension peak torque at week 36
Tidsramme: Week 16 and week 36
Determined by a Biodex isokinetic dynamometer, during a isometric knee extension contraction
Week 16 and week 36
Between group differences in isometric knee extension rate of force development at week 16
Tidsramme: Week 16
Determined by a Biodex isokinetic dynamometer, during a isometric knee extension contraction
Week 16
Between group differences in isometric knee extension rate of force development at week 36
Tidsramme: Week 36
Determined by a Biodex isokinetic dynamometer, during a isometric knee extension contraction
Week 36
Changes from baseline in isometric knee extension rate of force development at week 16
Tidsramme: Baseline and week 16
Determined by a Biodex isokinetic dynamometer, during a isometric knee extension contraction
Baseline and week 16
Changes from baseline in isometric knee extension rate of force development at week 36
Tidsramme: Baseline and week 36
Determined by a Biodex isokinetic dynamometer, during a isometric knee extension contraction
Baseline and week 36
Changes from week 16 in isometric knee extension rate of force development at week 36
Tidsramme: Week 16 and week 36
Determined by a Biodex isokinetic dynamometer, during a isometric knee extension contraction
Week 16 and week 36
Between group differences in upper body strength at week 16
Tidsramme: Week 16
Determined by a handgrip dynamometer.
Week 16
Between group differences in upper body strength at week 36
Tidsramme: Week 36
Determined by a handgrip dynamometer.
Week 36
Changes from baseline in upper body strength at week 16
Tidsramme: Baseline and week 16
Determined by a handgrip dynamometer.
Baseline and week 16
Changes from baseline in upper body strength at week 36
Tidsramme: Baseline and week 36
Determined by a handgrip dynamometer.
Baseline and week 36
Changes from week 16 in upper body strength at week 36
Tidsramme: Week 16 and week 36
Determined by a handgrip dynamometer.
Week 16 and week 36
Between group differences in postural balance at week 16
Tidsramme: Week 16
Determined by the number of falls in a single-legged flamingo balance test.
Week 16
Between group differences in postural balance at week 36
Tidsramme: Week 36
Determined by the number of falls in a single-legged flamingo balance test.
Week 36
Changes from baseline in postural balance at week 16
Tidsramme: Baseline and week 16
Determined by the number of falls in a single-legged flamingo balance test.
Baseline and week 16
Changes from baseline in postural balance at week 36
Tidsramme: Baseline and week 36
Determined by the number of falls in a single-legged flamingo balance test.
Baseline and week 36
Changes from week 16 in postural balance at week 36
Tidsramme: Week 16 and week 36
Determined by the number of falls in a single-legged flamingo balance test.
Week 16 and week 36
Between group differences in aerobic performance at week 16
Tidsramme: Week 16
Determined by meters covered in the Yo-Yo intermittent endurance level 1 test.
Week 16
Between group differences in aerobic performance at week 36
Tidsramme: Week 36
Determined by meters covered in the Yo-Yo intermittent endurance level 1 test.
Week 36
Changes from baseline in aerobic performance at week 16
Tidsramme: Baseline and week 16
Determined by meters covered in the Yo-Yo intermittent endurance level 1 test.
Baseline and week 16
Changes from baseline in aerobic performance at week 36
Tidsramme: Baseline and week 36
Determined by meters covered in the Yo-Yo intermittent endurance level 1 test.
Baseline and week 36
Changes from week 16 in aerobic performance at week 36
Tidsramme: Week 16 and week 36
Determined by meters covered in the Yo-Yo intermittent endurance level 1 test.
Week 16 and week 36
Between group differences in total cholesterol at week 16
Tidsramme: Week 16
Determined by an automated analyser.
Week 16
Between group differences in total cholesterol at week 36
Tidsramme: Week 36
Determined by an automated analyser.
Week 36
Changes from baseline in total cholesterol at week 16
Tidsramme: Baseline and week 16
Determined by an automated analyser.
Baseline and week 16
Changes from baseline in total cholesterol at week 36
Tidsramme: Baseline and week 36
Determined by an automated analyser.
Baseline and week 36
Changes from week 16 in total cholesterol at week 36
Tidsramme: Week 16 and week 36
Determined by an automated analyser.
Week 16 and week 36
Between group differences in high-density lipoprotein cholesterol at week 16
Tidsramme: Week 16
Determined by an automated analyser.
Week 16
Between group differences in high-density lipoprotein cholesterol at week 36
Tidsramme: Week 36
Determined by an automated analyser.
Week 36
Changes from baseline in high-density lipoprotein cholesterol at week 16
Tidsramme: Baseline and week 16
Determined by an automated analyser.
Baseline and week 16
Changes from baseline in high-density lipoprotein cholesterol at week 36
Tidsramme: Baseline and week 36
Determined by an automated analyser.
Baseline and week 36
Changes from week 16 in high-density lipoprotein cholesterol at week 36
Tidsramme: Week 16 and week 36
Determined by an automated analyser.
Week 16 and week 36
Between group differences in low-density lipoprotein cholesterol at week 16
Tidsramme: Week 16
Determined by an automated analyser.
Week 16
Between group differences in low-density lipoprotein cholesterol at week 36
Tidsramme: Week 36
Determined by an automated analyser.
Week 36
Changes from baseline in low-density lipoprotein cholesterol at week 16
Tidsramme: Baseline and week 16
Determined by an automated analyser.
Baseline and week 16
Changes from baseline in low-density lipoprotein cholesterol at week 36
Tidsramme: Baseline and week 36
Determined by an automated analyser.
Baseline and week 36
Changes from week 16 in low-density lipoprotein cholesterol at week 36
Tidsramme: Week 16 and week 36
Determined by an automated analyser.
Week 16 and week 36
Between group differences in triglycerides at week 16
Tidsramme: Week 16
Determined by an automated analyser.
Week 16
Between group differences in triglycerides at week 36
Tidsramme: Week 36
Determined by an automated analyser.
Week 36
Changes from baseline in triglycerides at week 16
Tidsramme: Baseline and week 16
Determined by an automated analyser.
Baseline and week 16
Changes from baseline in triglycerides at week 36
Tidsramme: Baseline and week 36
Determined by an automated analyser.
Baseline and week 36
Changes from week 16 in triglycerides at week 36
Tidsramme: Week 16 and week 36
Determined by an automated analyser.
Week 16 and week 36
Between group differences in fasting glucose at week 16
Tidsramme: Week 16
Determined by an automated analyser.
Week 16
Between group differences in fasting glucose at week 36
Tidsramme: Week 36
Determined by an automated analyser.
Week 36
Changes from baseline in fasting glucose at week 16
Tidsramme: Baseline and week 16
Determined by an automated analyser.
Baseline and week 16
Changes from baseline in fasting glucose at week 36
Tidsramme: Baseline and week 36
Determined by an automated analyser.
Baseline and week 36
Changes from week 16 in fasting glucose at week 36
Tidsramme: Week 16 and week 36
Determined by an automated analyser.
Week 16 and week 36
Between group differences in fasting insulin at week 16
Tidsramme: Week 16
Determined by an automated analyser.
Week 16
Between group differences in fasting insulin at week 36
Tidsramme: Week 36
Determined by an automated analyser.
Week 36
Change from baseline in fasting insulin at week 16
Tidsramme: Baseline and week 16
Determined by an automated analyser.
Baseline and week 16
Change from baseline in fasting insulin at week 36
Tidsramme: Baseline and week 36
Determined by an automated analyser.
Baseline and week 36
Change from week 16 in fasting insulin at week 36
Tidsramme: Week 16 and week 36
Determined by an automated analyser.
Week 16 and week 36
Between group differences in glucose tolerance at week 16
Tidsramme: Week 16
Determined by an oral glucose tolerance teste, analysed by an automated analyser.
Week 16
Between group differences in glucose tolerance at week 36
Tidsramme: Week 36
Determined by an oral glucose tolerance teste, analysed by an automated analyser.
Week 36
Changes from baseline in glucose tolerance at week 16
Tidsramme: Baseline and week 16
Determined by an oral glucose tolerance teste, analysed by an automated analyser.
Baseline and week 16
Changes from baseline in glucose tolerance at week 36
Tidsramme: Baseline and week 36
Determined by an oral glucose tolerance teste, analysed by an automated analyser.
Baseline and week 36
Changes from week 16 in glucose tolerance at week 36
Tidsramme: Week 16 and week 36
Determined by an oral glucose tolerance teste, analysed by an automated analyser.
Week 16 and week 36

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Sponsor

University Institute of Maia

Samarbeidspartnere

University of Southern Denmark
Universidade do Porto
Research Centre in Physical Activity, Health and Leisure, Faculty of Sport, University of Porto
Research Center in Sports Sciences, Health Sciences and Human Development (CIDESD)
Centre of Research, Education, Innovation and Intervention in Sport, University of Porto
Porto Sports Medicine Center (IPDJ, IP)
Gaia City Hall
Portuguese Handball Federation
São João University Hospital Centre
EPIUnit, Public Health Institute, University of Porto
Laboratory of Metabolism and Exercise (LaMetEx), CIAFEL, Faculty of Sport, University of Porto
European Handball Federation

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

2. januar 2016

Primær fullføring (Faktiske)

1. mars 2018

Studiet fullført (Faktiske)

1. mars 2018

Datoer for studieregistrering

Først innsendt

14. mars 2022

Først innsendt som oppfylte QC-kriteriene

14. mars 2022

Først lagt ut (Faktiske)

23. mars 2022

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

6. april 2022

Siste oppdatering sendt inn som oppfylte QC-kriteriene

28. mars 2022

Sist bekreftet

1. mars 2022

Mer informasjon

Begreper knyttet til denne studien

Andre studie-ID-numre

  • CEFADE202019

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Kliniske studier på Recreational team handball

Søk i lignende forsøk

Sponsorer og samarbeidspartnere

Medisinsk tilstand

Legemiddelintervensjoner

CROs by country

CROs in Malaysia

Forhold

Sjeldne sykdommer

Legemiddelintervensjoner

Kosttilskudd

Sponsor / samarbeidspartnere

Steder

3
Abonnere